Why do 50-70% of FTD cases occur sporadically without identifiable genetic mutations?

OPEN

Despite identifying multiple FTD-associated genes, the majority of cases remain genetically unexplained. This knowledge gap limits understanding of disease pathogenesis and prevents development of comprehensive therapeutic strategies. Gap type: open_question Source paper: [Frontotemporal dementia: clinical features, genetics, pathogenesis and treatment]. (2013, Harefuah, PMID:24416825)

Priority: 0.76 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: Why do 50-70% of FTD cases occur sporadically without identifiable genetic mutations? is a 0.76 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Why do 50-70% of FTD cases occur sporadically without identifiable genetic mutations? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (2)

ALSFTDLC3FTD

associated with (23)

PARKINSON'S DISEASEFTDALZHEIMER'S DISEASEFTDTARDBPFTDALSFTDTAUFTD
▸ Show 18 more

biomarker for (2)

Tau 3R/4R RatioFTDCryptic Hdgfl2FTD

causes (7)

ALSFTDTARDBPFTDTDP-43FTDC9ORF72FTDC9ORF72 REPEAT RNAFTD
▸ Show 2 more

contributes to (2)

Rbp DysfunctionFTDstress_granule_formationFTD

cross disease mechanism in (5)

TARDBPFTDC9ORF72FTDMAPTFTDTIA1FTDTBK1FTD

implicated in (1)

G3BP1FTD

interacts with (3)

ALSFTDFTDLRRK2FTDNEURONS

regulates (1)

ALSFTD

risk factor for (4)

C9orf72 expansionsFTDGgggcc Repeat ExpansionFTDC9orf72 HREFTDTBK1FTD
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps